New CAR T-Cell Therapy Shows Promise in Trial for Leukemia – The Scientist
The Scientist |
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
The Scientist ISTOCK, DR_MICROBEResearchers report promising results in a Phase 1 trial testing a new cell therapy using chimeric antigen receptor (CAR) T-cell technology on patients suffering from a treatment-resistant form of leukemia. The study, which … A New Target for CAR T Cells Achieves Remission in Resistant Pediatric B-ALL Stanford trial points to a new CAR–T drug, spotlighting a fresh target for next-gen cell therapies Clinical Trial Suggests New Cell Therapy for Relapsed Leukemia Patients |
